Generation of a Complete Set of Precise Null Bar-Coded Deletion Mutants of Mycobacterium tuberculosis
- Institution
- ALBERT EINSTEIN COLLEGE OF MEDICINE, NY
- Principal investigator
- William Robert Jacobs
- Funding
- $645K
- Duration
- 2017–2028
Moonbase score
Still being scored
Abstract
Project Abstract Tuberculosis (TB) continues to be a major global health problem with 9 million new cases per year resulting in 1.7 million deaths, due in large part to the HIV epidemic and emergence of multi- and extensively drug resistant TB strains (MDR- and XDR-TB) that have confounded TB control. There will be no lasting reduction of TB morbidity and mortality without rapid and cost-effective TB diagnostics, efficacious vaccines, and shortened, well-tolerated chemotherapy, which can only be developed on the foundation of understanding the biology of the tubercle bacilli and subsequent host-pathogen interactions. The goal of this proposal is to accelerate TB research through the completion and distribution of 4,000 specialized transducing reagents to make precise null bar-coded deletion (PNBCD) mutants in every gene of M. tuberculosis. We plan to make mutants in virulent Mtb strains and mc27902, an attenuated Mtb strain that can be used under BSL2-containment. We will partner with ATCC (BEI) for distribution of these and distribution
Research team
- William Robert JacobsPI
- Marco RiojasPI
LOADING MOONBASE SCORE
Questions for ALBERT EINSTEIN COLLEGE OF MEDICINE
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Albert Einstein College of MedicineNot yet scored
Esx5 secretome in TB and TB-HIV pathogenesis and immunity
William Ramses Bishai · $820K · 2025–2030
- NIH · Albert Einstein College of MedicineNot yet scored
Molecular Genetic Analysis of Mycobacterium Tuberculosis
William Robert Jacobs · $778K · 1988–2028
- NIH · Albert Einstein College of Medicine62
New Insight of Androgen Signaling in Prostate Cancer Initiation and Progression
Zijie Sun · $197K · 2024–2028